|
CKAP2L expression based on
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.763000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.636600E-01 |
| Normal-vs-Stage2 |
1.225230E-01 |
| Normal-vs-Stage3 |
6.375000E-01 |
| Normal-vs-Stage4 |
7.250800E-01 |
| Stage1-vs-Stage2 |
6.260000E-03 |
| Stage1-vs-Stage3 |
6.732800E-01 |
| Stage1-vs-Stage4 |
2.521200E-01 |
| Stage2-vs-Stage3 |
5.305500E-02 |
| Stage2-vs-Stage4 |
7.305000E-03 |
| Stage3-vs-Stage4 |
2.218000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.850200E-01 |
| Normal-vs-AfricanAmerican |
4.743200E-01 |
| Normal-vs-Asian |
6.467400E-01 |
| Caucasian-vs-AfricanAmerican |
4.245200E-01 |
| Caucasian-vs-Asian |
5.152000E-01 |
| AfricanAmerican-vs-Asian |
6.642200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.241800E-01 |
| Normal-vs-Female |
6.652600E-01 |
| Male-vs-Female |
8.738600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.665600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.364400E-01 |
| Normal-vs-Age(61-80Yrs) |
6.969000E-01 |
| Normal-vs-Age(81-100Yrs) |
4.353400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.193900E-04 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.939600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.336200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.376440E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.140980E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.407590E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.193000E-01 |
| Classical-VS-Follicular |
4.239600E-04 |
| Classical-VS-Other |
6.308300E-02 |
| Classical-VS-Normal |
9.569800E-01 |
| Tall-VS-Follicular |
4.562100E-02 |
| Tall-VS-Other |
9.799600E-02 |
| Tall-VS-Normal |
7.625200E-01 |
| Follicular-VS-Other |
9.202400E-01 |
| Follicular-VS-Normal |
1.107830E-01 |
| Other-VS-Normal |
1.958760E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.911600E-01 |
| Normal-vs-N1 |
6.565600E-01 |
| N0-vs-N1 |
4.371800E-01 |
|
|
